In conclusion, the current study suggests that a low level of MUC2 expression is an independent factor of poor prognosis in colorectal cancer and also associated with later TNM stage, presence of lymph node metastasis, rectal tumor site, and large tumor size. This evidence concerns the gene MUC2 and colorectal cancer.